Notes from the Field: Phenibut Exposures Reported to Poison Centers

was historically one of the most prominent brands for phenibut. However, due to shifting regulations and retailer policies, its availability has changed significantly:

The U.S. Food and Drug Administration (FDA) does not recognize phenibut as a legal dietary ingredient. It has issued warnings to companies for marketing it as such, noting that it does not meet the definition of a "dietary supplement".

Phenibut ( -aminobutyric acid) is a synthetic derivative of the neurotransmitter (gamma-aminobutyric acid) that was developed in the 1960s by Russian scientists. While it is prescribed as a pharmaceutical drug in Russia (under names like Noofen ) to treat anxiety, insomnia, and alcohol withdrawal, it is marketed in the United States and Europe primarily as a nootropic or dietary supplement for "cognitive enhancement" and stress relief. Understanding the Risks and Status

Before considering a purchase, it is vital to understand the regulatory and health landscape of this substance:

Users often report a very rapid buildup of tolerance. Some clinical reviews note that dependence can occur in less than a week, leading to severe withdrawal symptoms like panic attacks, tremors, and hallucinations.

Potential adverse effects include drowsiness, agitation, delirium, and in extreme cases, respiratory depression or kidney injury. Seeking Primaforce Phenibut